4.29. Analysis.

Comparison 4 BDP v BUD crossover design studies, no OCS: all delivery devices, Outcome 29 Night‐time use of rescue beta2 agonists (puffs/night).

Comparison 4 BDP v BUD crossover design studies, no OCS: all delivery devices, Outcome 29 Night‐time use of rescue beta2 agonists (puffs/night).